Weekly long-term intravenous immunoglobulin for refractory parvovirus B19 and Epstein-Barr virus-induced immune thrombocytopenic purpura

Tavil B., ÜNAL S., Aytaq-Elmas S., Yetgin S.

TURKISH JOURNAL OF PEDIATRICS, vol.50, no.1, pp.74-77, 2008 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 50 Issue: 1
  • Publication Date: 2008
  • Journal Name: TURKISH JOURNAL OF PEDIATRICS
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.74-77
  • Keywords: acute immune thrombocytopenic purpura, intracranial hemorrhage, parvovirus B19, Epstein-Barr virus, long-term IVIG treatment, ANTI-D TREATMENT, INTRACRANIAL HEMORRHAGE, INFECTION, CHILDHOOD, CHILDREN, ADULTS, ITP
  • Ankara University Affiliated: Yes

Abstract

In pediatric acute immune thrombocytopenic purpura (ITP) cases, it is usually among them, viral infections possible to determine an underlying pathology are the leading causative agents. In this report, we describe two cases of acute ITP complicated secondary to parvovirus B19 or Epstein-Barr virus (EBV) infections who were unresponsive to initial therapeutic measures, but who responded to long-term intravenous immunoglobulin (IVIG) treatment, given weekly for five to eight weeks.